Inventiva S.A. American Depository Shares Company Profile
NASDAQ: IVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:13 AM ET
Inventiva S.A. American Depository Shares at a glance
Inventiva S.A. American Depository Shares (NASDAQ: IVA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Daix, France. Inventiva S.A. American Depository Shares is led by Mr. Andrew Obenshain and employs about 87 people. The company's shares have traded publicly since 2020.
At a market capitalization of $795.1 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001756594, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Inventiva S.A. American Depository Shares do?
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
Business description based on the company's public filings.
Company information
- Legal name
- Inventiva S.A. American Depository Shares
- Ticker
- NASDAQ: IVA
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Andrew Obenshain
- Employees
- 87
- Headquarters
- 50 rue de Dijon, Daix, France
- Phone
- 33 3 80 44 75 00
- Website
- inventivapharma.com
- IPO year
- 2020
- Market cap
- $795.08M
- SEC CIK
- 0001756594
Companies similar to Inventiva S.A. American Depository Shares
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GERNGeron Corporation | 1.25 | +2.46% | $803.09M | vs IVA |
| APMDApnimed Inc. | 18.90 | +3.70% | $786.61M | vs IVA |
| HELPHelus Pharma Inc. | 10.72 | 0.00% | $783.21M | vs IVA |
| IMMXImmix Biopharma Inc. | 9.42 | +1.40% | $780.95M | vs IVA |
| OBXObsidian Therapeutics Inc. | 13.13 | +7.27% | $811.08M | vs IVA |
| LXRXLexicon Pharmaceuticals Inc. | 1.75 | -0.85% | $776.45M | vs IVA |
| ANNXAnnexon Inc. | 4.06 | +1.50% | $769.69M | vs IVA |
| ARDXArdelyx Inc. | 3.26 | -0.31% | $841.69M | vs IVA |